Conference Coverage
Conference Coverage
Single subcutaneous shot offers fast, potent platelet inhibition in STEMI
The effect was seen within 15 minutes of receiving RUC-4, an investigational glycoprotein IIb/IIIa inhibitor, with no thrombocytopenia, in a phase...
Conference Coverage
Full 2-year follow-up vindicates EVOLUT Low-Risk TAVR data
Bayesian estimates reported in 2019 based on 12-month data generated questions and had some crying foul over use of that statistical method.
Conference Coverage
What brought me back from the brink of suicide: A physician’s story
Dr. William Lynes said his “downward spiral into darkness” began with a series of catastrophic medical events starting in 1998.
Conference Coverage
Rivaroxaban cut recurrent limb events in VOYAGER-PAD
Conference Coverage
Daily cup of coffee cuts type 2 diabetes risk by about 5%
Beneficial effects may be caused by coffee’s ability to reduce inflammation.
Conference Coverage
Benefit from cooling temps for cardiac arrest does not differ in randomized trial
For major outcomes, cooling comatose cardiac arrest patients to 31° had no advantage over 34° in a controlled trial.
Conference Coverage
GALACTIC-HF: Novel drug most effective in sickest HFrEF patients
In GALACTIC-HF trial, the greatest relative benefit of omecamtiv mecarbil was in the sickest HFrEF patients.
Conference Coverage
Sotagliflozin’s HFpEF benefit confirmed by new analyses
Conference Coverage
Early aspirin withdrawal after PCI: More benefit for women?
Conference Coverage
FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
Conference Coverage
Dapagliflozin misses as treatment for COVID-19 but leaves intriguing signal for benefit
The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close.